Replies to post #98239 on Biotech Values

[mcbio]

Re: ARNA (Lorcaserin costs)

Jack Lief mentioned in the CC that the cost is very cheap and similar to other small molecules. Its only a 3 steps synthesis process, so I would think the cost will be in single digit % of total sales.

Thanks Tony. I think I largely agree with your thoughts in #msg-51919949 as I also don't believe the market is properly considering the efficacy of Lorcaserin, particularly as it relates to some patients who do even better on the drug. There's also the likelihood that Lorcaserin will be combined with phentermine to further boost efficacy. As I said in #msg-44771030, I won't touch the stock in front of the FDA's decision on approval, but if the drug is approved and shares don't increase too much (and they may not given what may be a tepid outlook by many on Lorcaserin sales due to efficacy concerns), I'd be very interested.